Cargando…

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma

Malignant mesothelioma (MM) is one of the most aggressive tumors. We conducted bioinformatics analysis using Cancer Cell Line Encyclopedia (CCLE) datasets to identify new molecular markers in MM. Overexpression of oxytocin receptor (OXTR), which is a G‐protein–coupled receptor for the hormone and ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kodama, Yuta, Tanaka, Ichidai, Sato, Tatsuhiro, Hori, Kazumi, Gen, Soei, Morise, Masahiro, Matsubara, Daisuke, Sato, Mitsuo, Sekido, Yoshitaka, Hashimoto, Naozumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409407/ https://www.ncbi.nlm.nih.gov/pubmed/34115916 http://dx.doi.org/10.1111/cas.15025

Ejemplares similares

Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
por: Gen, Soei, et al.
Publicado: (2022)

NF2 alteration in mesothelioma
por: Sekido, Yoshitaka, et al.
Publicado: (2023)

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
por: Sato, Tatsuhiro, et al.
Publicado: (2018)

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023)

Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
por: Fujii, Makiko, et al.
Publicado: (2012)

Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations
por: Tanaka, Ichidai, et al.
Publicado: (2021)

Is area under the curve the best parameter for carboplatin induced emetic risk stratification?
por: Ozone, Sachiko, et al.
Publicado: (2021)

An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib
por: Sato, Mitsuo, et al.
Publicado: (2018)

Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively
por: Sato, Tatsuhiro, et al.
Publicado: (2021)

Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer
por: Shimizu, Takahiro, et al.
Publicado: (2020)

The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence
por: Tanaka, Ichidai, et al.
Publicado: (2021)

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma
por: Shigeeda, Wataru, et al.
Publicado: (2017)

Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer
por: Matsuzawa, Reiko, et al.
Publicado: (2021)

eIF2β, a subunit of translation‐initiation factor EIF2, is a potential therapeutic target for non‐small cell lung cancer
por: Tanaka, Ichidai, et al.
Publicado: (2018)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
por: Tanaka, Ichidai, et al.
Publicado: (2023)

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma
por: Suzuki, Koya, et al.
Publicado: (2022)

CADM1 associates with Hippo pathway core kinases; membranous co–expression of CADM1 and LATS2 in lung tumors predicts good prognosis
por: Ito, Takeshi, et al.
Publicado: (2019)

The “bud” of an aortic aneurysm
por: Yamaguchi, Tetsuo, et al.
Publicado: (2021)

Silencing of GRHL2 induces epithelial‑to‑mesenchymal transition in lung cancer cell lines with different effects on proliferation and clonogenic growth
por: Kawabe, Nozomi, et al.
Publicado: (2023)

EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy
por: Satoh, Motohiko, et al.
Publicado: (2013)

TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
por: Fujii, Makiko, et al.
Publicado: (2012)

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
por: Li, Zan, et al.
Publicado: (2019)

Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma
por: Li, Qi, et al.
Publicado: (2015)

Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury
por: Takashima, Koji, et al.
Publicado: (2014)

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy
por: Omote, Norihito, et al.
Publicado: (2017)

Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2020)

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
por: Nakano, Takashi, et al.
Publicado: (2020)

Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer
por: Kakumu, Tomohiko, et al.
Publicado: (2017)

Infrequent Mutation of the hBUB1 and hBUBR1 Genes in Human Lung Cancer
por: Sato, Mitsuo, et al.
Publicado: (2000)

Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome
por: Majima, Suguru, et al.
Publicado: (2018)

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model
por: Ohara, Yuuki, et al.
Publicado: (2018)

Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells
por: Hakiri, Shuhei, et al.
Publicado: (2015)

Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
por: Hagiyama, Man, et al.
Publicado: (2022)

Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model
por: Minami, Daisuke, et al.
Publicado: (2015)

Acute Exacerbation of Pleuroparenchymal Fibroelastosis Secondary to Allogenic Hematopoietic Stem Cell Transplantation
por: Murakami, Yasushi, et al.
Publicado: (2020)

Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma
por: Sakakibara-Konishi, Jun, et al.
Publicado: (2020)

Role of oxytocin in improving the welfare of farm animals — A review
por: Chen, Siyu, et al.
Publicado: (2017)

Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma
por: Wang, Shenqi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rt49to6coa5uta29co6sku67bs